Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 35 /hr
Hire Samuel B.
United States
USD 35 /hr

Biomedical researcher with a background in developmental neurobiology, translational medicine, and cancer biology

Profile Summary
Subject Matter Expertise
Work Experience

Anatomy & Physiology Editor (Contractor)


February 2018 - June 2018

Editor - Neuroscience Center for Excellence

Cactus Communications

February 2017 - July 2017


Bachelors - Neuroscience

Skidmore College

September 2008 - May 2012

  • Certification details not provided.
Samuel Brook, Moshe Elkabets(2018). Methods to Study the Role of Progranulin in the Tumor Microenvironment . 155--176Springer New York
Samuel Brook, Aviram Mizrachi, Yosi Shamay, Janki Shah, Joanne Soong, Vinagolu K. Rajasekhar, John L. Humm, John H. Healey, Simon N. Powell, José Baselga, et al.(2017). Tumour-specific {PI}3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma . Nature Communications. 8. p. 14292. Springer Nature
Y. Shamay, M. Elkabets, H. Li, J. Shah, S. Brook, F. Wang, K. Adler, E. Baut, M. Scaltriti, P. V. Jena, et al.(2016). P-selectin is a nanotherapeutic delivery target in the tumor microenvironment . Science Translational Medicine. 8. (345). p. 345ra87--345ra87. American Association for the Advancement of Science ({AAAS})
Samuel Brook, Moshe Elkabets, Evangelos Pazarentzos, Dejan Juric, Qing Sheng, Raphael A. Pelossof, Ana Oaknin Benzaken, Jordi Rodon, Natasha Morse, Jenny Jiacheng Yan, et al.(2015). {AXL} Mediates Resistance to {PI}3K$\upalpha$ Inhibition by Activating the {EGFR}/{PKC}/{mTOR} Axis in Head and Neck and Esophageal Squamous Cell Carcinomas . Cancer Cell. 27. (4). p. 533--546. Elsevier {BV}